A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 01.08.2022 · 41 (4) · 202-209
DOI: 10.1089/mab.2021.0068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, online erschienen am 25.08.2022. Verfasst von Melissa T Bu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Blockade of the PD-L1/PD-1 pathway has proven to be a broadly effective cancer immunotherapy. FDA-approved therapeutic monoclonal antibodies (mAbs) targeting the pathway have high affinity, blocking capacity, and low antibody effector activity. A number of rat antimouse mAbs have been used to model cancer immunotherapy in mouse models. We set forth the amino acid sequences of mAbs specific for mouse PD-1 (29F.1A12) and PD-L1 (10F.9G2) and compare their avidities, blocking capacities, biological activities, and epitope recognition with other commonly used mAbs. Further manipulation of these sequences should facilitate better modeling of immunotherapy in mouse models and the generation of novel agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Melissa T Bu
Förderung
- NIAID NIH HHS
Zitieren
APA
Bu, M. T., Yuan, L., Klee, A. N., & Freeman, G. J. (2022). A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 41(4), 202-209. https://doi.org/10.1089/mab.2021.0068
Vancouver
Bu MT, Yuan L, Klee AN, Freeman GJ. A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2022;41(4):202-209. doi:10.1089/mab.2021.0068
BibTeX
@article{Bu2022,
author = {Bu, Melissa T and Yuan, Long and Klee, Alyssa N and Freeman, Gordon J},
title = {A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2022},
volume = {41},
number = {4},
pages = {202--209},
doi = {10.1089/mab.2021.0068}
}
EUVIMED